US Regulation

Ikuti

PreCheck Program Expands Manufacturing

Dilaporkan oleh AI

The PreCheck program was launched to boost domestic pharmaceutical manufacturing in the US. It focuses on increasing production capacity and supply chain resilience. Regulatory developments also include blood-based tests for Alzheimer's detection.

Situs web ini menggunakan cookie

Kami menggunakan cookie untuk analisis guna meningkatkan situs kami. Baca kebijakan privasi kami kebijakan privasi untuk informasi lebih lanjut.
Tolak